Synapse - Renier Brentjens

Search Within

Renier J Brentjens

Results (286)

Decreased neuroprotective analytes on day of infusion of chimeric antigen receptor (CAR) T cells are associated with neurotoxicity

Meeting Abstract

Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Khakoo, Y.; Santomasso, B. D.; Riviere, I.; Sadelain, M.; Curran, K. J.; more...
Bone Marrow Transplantation (2021)

Fulltext@MSK | Save

Predictors for neurotoxicity on day of infusion of chimeric antigen receptor (CAR) T cells using discovery proteomics platform

Meeting Abstract

Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
Cytotherapy (2021)

Fulltext@MSK | Save

Bispecific T-cell engaging antibodies against MUC16 demonstrate efficacy against ovarian cancer in monotherapy and in combination with PD-1 and VEGF inhibition

Journal Article

Yeku, O. O.; Rao, T. D.; Laster, I.; Kononenko, A.; Purdon, T. J.; Wang, P.; Cui, Z.; Liu, H.; Brentjens, R. J.; Spriggs, D.
Frontiers in Immunology (2021)

Fulltext@MSK | Save

Chimeric antigen receptor-modified immune effector cell therapies: Learning from the present; charting a path to the future

Editorial

Smith, E. L.; Brentjens, R. J.
The Cancer Journal (2021)

Fulltext@MSK | Save

Frontiers in cancer immunotherapy - A symposium report

Editorial

Cable, J.; Greenbaum, B.; Pe'er, D.; Bollard, C. M.; Bruni, S.; Griffin, M. E.; Allison, J. P.; Wu, C. J.; Subudhi, S. K.; Mardis, E. R.; more...
Annals of the New York Academy of Sciences (2021)

Fulltext@MSK | Save

Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response

Journal Article

Li, X.; Daniyan, A. F.; Lopez, A. V.; Purdon, T. J.; Brentjens, R. J.
Leukemia (2021)

Fulltext@MSK | Save

Proceedings from the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar

Review

Guerrouahen, B.; Elnaggar, M.; Al-Mohannadi, A.; Kizhakayil, D.; Bonini, C.; Benjamin, R.; Brentjens, R.; Buchholz, C. J.; Casorati, G.; Ferrone, S.; more...
Frontiers in Immunology (2021)

Fulltext@MSK | Save

Defining an optimal dual-targeted CAR T-cell therapy approach simultaneously targeting BCMA and GPRC5D to prevent BCMA escape– Driven relapse in multiple myeloma

Journal Article

de Larrea, C. F.; Staehr, M.; Lopez, A. V.; Ng, K. Y.; Chen, Y.; Godfrey, W. D.; Purdon, T. J.; Ponomarev, V.; Wendel, H. G.; Brentjens, R. J.; more...
Blood Cancer Discovery (2020)

Fulltext@MSK | Save

A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory B-cell malignancies

Meeting Abstract

Park, J. H.; Riviere, I.; Sikder, D. S.; Bermudez, V. P.; Senechal, B.; Wang, X.; Auchincloss, T. H.; Diamonte, C.; Halton, E.; Palomba, M. L.; more...
Blood (2020)

Fulltext@MSK | Save

International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells

Meeting Abstract

Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
Bone Marrow Transplantation (2020)

Fulltext@MSK | Save